Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis

NCT01244958 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Rituximab
DRUG: Placebo

Sponsor

Frank Behrens